Form 4: Unity Biotechnology Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Alexander Hieu Nguyen, Chief Legal Officer of Unity Biotechnology, sold shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- On August 2, 2024, Alexander Hieu Nguyen, the Chief Legal Officer of Unity Biotechnology, sold 154 shares of common stock at a price of $1.53 per share.
- The sale was executed under a Rule 10b5-1 trading plan to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Nguyen directly owns 24,872 shares, which includes unvested Restricted Stock Units.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction to cover tax obligations, which is a common practice among executives. It doesn't necessarily reflect a positive or negative view of the company's future.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders. Sales to cover tax obligations are common and don't necessarily indicate a negative outlook on the company.
Stakeholder Impact
- The sale is unlikely to have a significant impact on shareholders, as it is a small transaction related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 08/02/2024 | Date of the stock sale transaction. |
| 08/06/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.